The University of Chicago Header Logo

Connection

Jonathan Chung to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Jonathan Chung has written about Antibodies, Monoclonal.
Jonathan Chung
Connection Strength
0.100
Antibodies, Monoclonal
  1. An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis. Eur Urol. 2019 01; 75(1):201-203.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.